133 related articles for article (PubMed ID: 31887826)
1. [Advances in immunotherapy of extranodal NK/T cell lymphoma].
Hao DQ; Li LQ; Li MC; Gong LL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Dec; 54(12):949-953. PubMed ID: 31887826
[TBL] [Abstract][Full Text] [Related]
2. Treatment of extranodal NK/T-cell lymphoma: From past to future.
Yan Z; Yao S; Wang Z; Zhou W; Yao Z; Liu Y
Front Immunol; 2023; 14():1088685. PubMed ID: 36825002
[TBL] [Abstract][Full Text] [Related]
3. The landscape of new drugs in extranodal NK/T-cell lymphoma.
Wang L; Li LR; Zhang L; Wang JW
Cancer Treat Rev; 2020 Sep; 89():102065. PubMed ID: 32653806
[TBL] [Abstract][Full Text] [Related]
4. Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
Hu B; Oki Y
Front Oncol; 2018; 8():139. PubMed ID: 29761078
[TBL] [Abstract][Full Text] [Related]
5. Selection of new immunotherapy targets for NK/T cell lymphoma.
Lv K; Li X; Yu H; Chen X; Zhang M; Wu X
Am J Transl Res; 2020; 12(11):7034-7047. PubMed ID: 33312349
[TBL] [Abstract][Full Text] [Related]
6. [Research Advances on Extranodal Nasal Type NK/T Cell Lymphoma--Review].
Yu G; Chen JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):271-4. PubMed ID: 26913435
[TBL] [Abstract][Full Text] [Related]
7. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.
Cho SG; Kim N; Sohn HJ; Lee SK; Oh ST; Lee HJ; Cho HI; Yim HW; Jung SE; Park G; Oh JH; Choi BO; Kim SW; Kim SW; Chung NG; Lee JW; Hong YS; Kim TG
Mol Ther; 2015 Aug; 23(8):1401-1409. PubMed ID: 26017177
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
10. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
Chang BH; Stork L; Fan G
Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
[TBL] [Abstract][Full Text] [Related]
11. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
12. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
13. Novel targets for natural killer/T-cell lymphoma immunotherapy.
Kumai T; Kobayashi H; Harabuchi Y
Immunotherapy; 2016; 8(1):45-55. PubMed ID: 26642249
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
16. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
[TBL] [Abstract][Full Text] [Related]
17. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
19. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
Devins K; Schuster SJ; Caponetti GC; Bogusz AM
Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]